Simin Gharib Lee, MD, MBA, Co-Founder & CEO, Systole Health
We have a problem. Millions of Americans—especially women—are trapped in a healthcare system that cannot see them, hear them, or treat them in time.
Nearly half…
Continue Reading
Radiology has always been ahead of the curve when it comes to adopting new technology—but what’s driving its rapid embrace of AI today? In this interview, Vijay Ramanathan, Co-Founder and CEO of RamSoft, breaks…
Continue Reading
It’s a common misconception that marketing only becomes involved in the last stage of a medtech product’s launch. In actuality, medtech marketing is – or should be – collaborating throughout the entire product lifecycle.
From…
Continue Reading
Many people are dealing with a medication mess. They get prescriptions from different specialties (neurology, cardiology, etc.), who are busy and can't always check for contraindications or adverse effects. The patient then picks up…
Continue Reading
In this case study, Moyeen Ahmad, the founder of Vitacam, shares how the Leap programme helped to facilitate involvement and co-design, ensuring people with lived experience of chronic conditions were at the heart of…
Continue Reading
Welcome to our exclusive digital health interview with Jennifer Owens, Senior AI Program Administrator at Cleveland Clinic. In this in-depth conversation, Jennifer opens up about her personal journey, detailing her background and how she…
Continue Reading
Evinova, a clinical trial technology company, is partnering with Quantum Leap Healthcare Collaborative (QLHC) to integrate Evinova’s remote patient monitoring (RPM) offering into I-SPY 2.2, a platform trial that provides a framework to study…
Continue Reading
Migraine impacts millions worldwide, causing severe pain, nausea, and sensitivity to light and sound. While prescription medications may help, they aren’t the only option. There are some innovative and scientifically backed techniques like nerve…
Continue Reading
Timely detection of atrial fibrillation (AF) is crucial for the prevention of serious consequences such as stroke and heart failure, yet it remains challenging due to its often asymptomatic or paroxysmal nature. Wearable devices…
Continue Reading
What You Should Know:
– 23andMe, a human genetics and biotechnology company, has announced its decision to initiate voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri.
– The bankruptcy…
Continue Reading
